ATS: Pirfenidone Slows IPF Lung Declines

Courtesy MedPage Today Allergy & Immunology  Tue, 05/20/2008 - 15:05

TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here.


 

More related items

Living with a partner reduces risk of Alzheimer's
(Karolinska Institutet) Living with a spouse or a partner decreases the risk of developing Alzheimer's and other dementia diseases. This according to...

Allograft ACL Repair Questioned in Young Active Patients
ORLANDO -- Using tissue from cadavers to reconstruct anterior cruciate ligaments in young active patients is associated with a failure rate of nearly...

Researcher say that ICSI may be over-used in some countries
(European Society for Human Reproduction and Embryology) New figures on assisted reproduction technology in Europe show that there has been an...

Blood test for lung cancer may be possible
(American Thoracic Society) A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to...

A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...

What Your Doctor May Not Tell You About Fibromyalgia: The...
In this book Dr. R. Paul St. Amand offers the first effective protocol to help reverse the autoimmune disorder, Fibromyalgia, in children. The...

Good Calories, Bad Calories
In this groundbreaking book, the result of seven years of research in every science connected with the impact of nutrition on health, award-winning...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com